This was the concern with the mismatching sample groups. If the decreased efficacy was because of age differences rather the dosing differences - congrats! You

This was the concern with the mismatching sample groups. If the decreased efficacy was because of age differences rather the dosing differences - congrats! You just convinced the entire UK to adopt only a significant alt wise dosing scheme because the vaccine is actually worse at people Over 65. The science behind this vaccine has been sloppily done. Let’s hope that the USA trials and the J&J vaccine make up for it.